ArticleFrontiers in immunology2026

Editorial: Precision therapeutics in rare cancers: targeting tumor microenvironment and biomarker-driven approaches.

Takahiro Tsujikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.